Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3 AND Diagnosis
5 results:

  • 1. Five circRNAs Serve as Potential Diagnostic and Prognostic Biomarkers in Lung Adenocarcinoma.
    Li Z; Ma G; Pan Y
    Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383411
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MiR-196: emerging of a new potential therapeutic target and biomarker in colorectal cancer.
    Pourdavoud P; Pakzad B; Mosallaei M; Saadatian Z; Esmaeilzadeh E; Alimolaie A; Shaygannejad A
    Mol Biol Rep; 2020 Dec; 47(12):9913-9920. PubMed ID: 33130965
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
    Vedeld HM; Merok M; Jeanmougin M; Danielsen SA; Honne H; Presthus GK; Svindland A; Sjo OH; Hektoen M; Eknaes M; Nesbakken A; Lothe RA; Lind GE
    Int J Cancer; 2017 Sep; 141(5):967-976. PubMed ID: 28542846
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Suspicious macroscopic features of small malignant colorectal polyps.
    Bugajski M; Kaminski MF; Orlowska J; Mroz A; Pachlewski J; Rupinski M; Zagorowicz E; Rawa T; Regula J
    Scand J Gastroenterol; 2015; 50(10):1261-7. PubMed ID: 25865832
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer.
    Kawasaki T; Ohnishi M; Suemoto Y; Kirkner GJ; Liu Z; Yamamoto H; Loda M; Fuchs CS; Ogino S
    Mod Pathol; 2008 Feb; 21(2):150-8. PubMed ID: 18084250
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.